Fang Xiao-Ling, Tong Yao, Zhou Ya-Li, Zhao Pei-Quan, Wang Zhao-Yang
Department of Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center, Shanghai, China.
Department of Ophthalmology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Br J Ophthalmol. 2017 Nov;101(11):1535-1541. doi: 10.1136/bjophthalmol-2016-309768. Epub 2017 Mar 17.
To determine whether internal limiting membrane (ILM) peeling improves anatomical and functional outcomes in idiopathic macular pucker (IMP)/epiretinal membrane (ERM) surgery in this systematic review and meta-analysis.
We searched the PubMed, Medline, Web of Science, Cochrane, Ovid MEDLINE, ClinicalTrials.gov and CNKI databases for studies published before 15 September 2016. The eligibility criteria included studies comparing ILM peeling versus no-peeling for IMP surgery.
Thirteen articles (10 retrospective cohort studies, 1 prospective cohort study and 2 randomised controlled trials (RCTs)) were included in the review. Primary outcomes: no differences were observed in the best-corrected visual acuity (BCVA) or central macular thickness (CMT) at 12 months; however, lower ERM recurrence (OR, 0.13; 95% CI 0.04 to 0.41; p=0.0004) and reoperation rates (OR, 0.10; 95% CI 0.02 to 0.49; p=0.004) that favoured ILM peeling were observed at the final follow-up.
no difference was observed in BCVA at 3, 6 months, the final follow-up or in CMT at 3, 6 months, the final follow-up. Significantly increased CMT, which favoured ILM peeling, was observed at the final follow-up (p=0.002) in the RCTs.
ILM peeling yielded greater anatomical success, but no improvement in functional outcomes as the treatment of choice for patients undergoing IMP surgery.
在本系统评价和荟萃分析中,确定内界膜(ILM)剥除术是否能改善特发性黄斑皱襞(IMP)/视网膜前膜(ERM)手术的解剖和功能结局。
我们检索了截至2016年9月15日发表的PubMed、Medline、Web of Science、Cochrane、Ovid MEDLINE、ClinicalTrials.gov和中国知网数据库。纳入标准包括比较IMP手术中ILM剥除术与未剥除术的研究。
本评价纳入了13篇文章(10项回顾性队列研究、1项前瞻性队列研究和2项随机对照试验(RCT))。主要结局:12个月时,最佳矫正视力(BCVA)或中心黄斑厚度(CMT)无差异;然而,在最终随访时,观察到有利于ILM剥除术的较低ERM复发率(OR,0.13;95%CI 0.04至0.41;p = 0.0004)和再次手术率(OR,0.10;95%CI 0.02至0.49;p = 0.004)。
在3、6个月、最终随访时的BCVA以及在3、6个月、最终随访时的CMT均无差异。在RCT中,最终随访时观察到有利于ILM剥除术的显著增加的CMT(p = 0.002)。
作为IMP手术患者的首选治疗方法,ILM剥除术在解剖学上取得了更大的成功,但在功能结局方面没有改善。